Grifols KIRO® Oncology is a robotic system focused on precision, flexibility, reliability, and safety throughout the highly complex process of compounding oncology medications. Grifols KIRO Fill is an automated compounding device designed to enhance patient safety and optimize operational efficiencies during the production of non-hazardous compounded sterile preparations. KIRO Fill uniquely reduces manual steps and adds automation where it makes the most sense. Grifols is a global healthcare company dedicated to improving the health and well-being of people around the world. Founded in Barcelona, Spain in 1940, Grifols now operates four divisions: Bioscience, Diagnostic, Hospital, and Bio Supplies, and employs 21,000 employees across 30 countries. The Grifols Hospital Division has leveraged its legacy of safety and compliance to the development of inclusiv®, a comprehensive portfolio of integrated technology, software, and services designed to help meet the challenges of producing compounded sterile preparations while supporting sustainable improvements in operational efficiencies. The portfolio includes cleanroom equipment and consulting, IV workflow management systems, robotics and other compounding devices, and operations software.
2410 Lillyvale Avenue
Los Angeles, CA 90032
This post is related to:Automation & Robotics